Dr. Rebecca Glaser, MD, recently reported a successful treatment for 1,000 women using testosterone plus an aromatase inhibitor (AI), which prevents conversion to estradiol. The AI is anastrozle. The patients have been followed up for 8 years and there has significantly been no recurrence of breast cancer, indicating that this approach works to stop breast cancer, as described by Ed Friedman in The New Testosterone Treatment.

The use of testosterone as part of hormone replacement therapy is highly advantageous to women on many levels. It boosts energy, fights breast cancer, and provides other health benefits.

An article summarizing Dr. Glaser’s remarkable results can be read here: “Testosterone / anastrozole implants relieve menopausal symptoms in breast cancer survivors.”

It is important to point out that testosterone is indicated for women even if they have not had breast cancer. As Ed Friedman explains, it is likely to protect against the occurrence of breast cancer.